Kevin Sharp, Senior Director of Business Development at Samsung Biologics, sat down with Bioprocess Insider editor Dan Stanton to discuss the company's agile response to the COVID-19 pandemic, the evolving role of the outsourcing manufacturing organization, and their future expansion plans.
Kevin Sharp, Senior Director of Business Development at Samsung Biologics, sat down with Bioprocess Insider editor Dan Stanton to discuss the company's agile response to the COVID-19 pandemic, the evolving role of the outsourcing manufacturing organization, and their future expansion plans.
- CDO
- CGMP
- ADC
- Bio Campus
- IR
- CMO
Share article